Group One Trading
EVFM

Group One Trading’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Group One Trading’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,066,500
Closed -$1.21M – 8710
2022
Q2 		$1.21M Buy
1,066,500
+1,044,613
+4,773% +$1.72M ﹤0.01% 2567
2022
Q1 		$112K Sell
21,887
-13,713
-39% -$86.2K ﹤0.01% 5387
2021
Q4 		$201K Sell
35,600
-11,507
-24% -$97.8K ﹤0.01% 5082
2021
Q3 		$522K Sell
47,107
-3,073
-6% -$38.6K ﹤0.01% 4147
2021
Q2 		$851K Buy
50,180
+38,487
+329% +$730K ﹤0.01% 3599
2021
Q1 		$307K Buy
11,693
+5,113
+78% +$232K ﹤0.01% 4549
2020
Q4 		$238K Buy
6,580
+2,680
+69% +$96.9K ﹤0.01% 3932
2020
Q3 		$138K Buy
3,900
+3,693
+1,784% +$161K ﹤0.01% 3947
2020
Q2 		$9K Buy
+207
New +$14K ﹤0.01% 5192

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Group One Trading's EVFM Position: Q2 2022 in Review

Group One Trading sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 26,463 shares — an estimated $43.6K sold.

Group One Trading first reported a position in EVFM in Q2 2020 and held it in 7 quarters. The position peaked at $599K in Q2 2021. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

  • Group One Trading reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 26,463 Evofem Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $43.6K.
  • Group One Trading first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Group One Trading's Evofem Biosciences, Inc. Common Stock position peaked at $599K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.